Detailed Description:
Autoimmune diseases only show local pathological damage, but more often systemic lesions. If not diagnosed and treated in time or poorly controlled, there is a risk of d...
chimeric-antigen-receptor-t-cell-therapy
Detailed Description:
This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis for collect...
chimeric-antigen-receptor-t-cell-therapy
Brief Summary:
A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma
Detailed Description:
This i...
chimeric-antigen-receptor-t-cell-therapy
March 2023: Immune thrombocytopenia (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. Approximately two-thirds of patients achieve remission after/during first-line therap...
chimeric-antigen-receptor-t-cell-therapy